August 20, 2024 August 20, 2024Categories News StoriesBlinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)
July 24, 2024 July 24, 2024Categories Press ReleasesPress Release: New England Journal of Medicine publishes practice-changing E1910 trial results
June 14, 2024 June 14, 2024Categories News StoriesE1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)
November 15, 2023 November 15, 2023Categories Press ReleasesPress Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023
February 15, 2023 February 15, 2023Categories AnnouncementsA participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger
February 10, 2023 February 10, 2023Categories Announcements News StoriesThe January/February 2023 News from ECOG-ACRIN blog is now available
January 5, 2023 January 5, 2023Categories Announcements News StoriesThe Winter 2023 advocacy blog Considering Clinical Trials is now available
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
December 19, 2022 December 19, 2022Categories News StoriesBlinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL
